Cargando…
Consequences of SPAK inactivation on Hyperkalemic Hypertension caused by WNK1 mutations: evidence for differential roles of WNK1 and WNK4
Mutations of the gene encoding WNK1 [With No lysine (K) kinase 1] or WNK4 cause Familial Hyperkalemic Hypertension (FHHt). Previous studies have shown that the activation of SPAK (Ste20-related Proline/Alanine-rich Kinase) plays a dominant role in the development of FHHt caused by WNK4 mutations. Th...
Autores principales: | Rafael, Chloé, Soukaseum, Christelle, Baudrie, Véronique, Frère, Perrine, Hadchouel, Juliette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818654/ https://www.ncbi.nlm.nih.gov/pubmed/29459793 http://dx.doi.org/10.1038/s41598-018-21405-x |
Ejemplares similares
-
SPAK/OSR1 regulate NKCC1 and WNK activity: analysis of WNK isoform interactions and activation by T-loop trans-autophosphorylation
por: Thastrup, Jacob O., et al.
Publicado: (2011) -
Role of the WNK-activated SPAK kinase in regulating blood pressure
por: Rafiqi, Fatema H, et al.
Publicado: (2010) -
SPAK Deficiency Corrects Pseudohypoaldosteronism II Caused by WNK4 Mutation
por: Chu, Pei-Yi, et al.
Publicado: (2013) -
Targeting the WNK-SPAK/OSR1 Pathway and Cation-Chloride Cotransporters for the Therapy of Stroke
por: Josiah, Sunday Solomon, et al.
Publicado: (2021) -
The WNK-SPAK/OSR1 Kinases and the Cation-Chloride Cotransporters as Therapeutic Targets for Neurological Diseases
por: Huang, Huachen, et al.
Publicado: (2019)